Amanda L Votaw, LMFT - Medicare Couples Therapy in Carmel, IN

Amanda L Votaw, LMFT is a medicare enrolled "Marriage & Family Therapist" provider in Carmel, Indiana. Her current practice location is 697 Pro Med Ln, Carmel, Indiana. You can reach out to her office (for appointments etc.) via phone at (317) 574-1254.

Amanda L Votaw is licensed to practice in Indiana (license number 35001940A) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1407308083.

Contact Information

Amanda L Votaw, LMFT
697 Pro Med Ln,
Carmel, IN 46032-5323
(317) 574-1254
(317) 674-0060

Healthcare Provider's Profile

Full NameAmanda L Votaw
GenderFemale
SpecialityMarriage & Family Therapist
Location697 Pro Med Ln, Carmel, Indiana
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1407308083
  • Provider Enumeration Date: 10/28/2016
  • Last Update Date: 04/10/2024
  Medicare PECOS Information:
  • PECOS PAC ID: 3072962562
  • Enrollment ID: I20231208002455

Medical Identifiers

Medical identifiers for Amanda L Votaw such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1407308083NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
106H00000XMarriage & Family Therapist 35001940A (Indiana)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Amanda L Votaw allows following entities to bill medicare on her behalf.
Entity NameAspire Indiana Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1124016050
PECOS PAC ID: 4486635455
Enrollment ID: O20041015000190

News Archive

Use of Prostate Health Index cuts down need for uncomfortable biopsies

The Prostate Health Index is a cost-effective tool used by urologists to detect prostate cancer. It reduces the risk of over diagnosis, and cuts down on the need to send men for unnecessary and often uncomfortable biopsies.

Researchers reveal how antipsychotics affect metabolism by SMAD3 activation

In a paper published January 31 in the journal Molecular Psychiatry, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) reveal how antipsychotic drugs interfere with normal metabolism by activating a protein called SMAD3, an important part of the transforming growth factor beta (TGFbeta) pathway.

WWHI participates in joint meeting to explore barriers to wireless communications, health care solutions

The West Wireless Health Institute today announced its participation in the first joint meeting hosted by the Federal Communications Commission and Food & Drug Administration to explore the potential barriers that may slow the convergence of wireless communications and health care solutions.

Novabay commences NVC-422 catheter Phase 2 trial to treat UCBE

NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing its first-in-class, anti-infective Aganocide compounds for the local non-systemic treatment and prevention of antibiotic-resistant infections, today provided an update on its Phase 2 clinical trial for the use of its lead compound, NVC-422, to prevent urinary catheter blockage and encrustation which is often a contributing factor to urinary tract infections in chronically catheterized patients.

R-Tech Ueno, Sucampo Pharmaceuticals request arbitration against Takeda Pharmaceutical

R-Tech Ueno supplies Amitiza (TM) Capsules to Takeda pursuant to agreements with Takeda and Sucampo. On March 12, 2010, Sucampo submitted for filing with the International Court of Arbitration, International Chamber of Commerce, a Request for Arbitration against Takeda. In that Request, Sucampo claimed that Takeda has violated the provisions of the October 29, 2004, Collaboration and License Agreement between Sucampo and Takeda and other applicable duties, and that Takeda's violations have injured Sucampo. Sucampo requested all appropriate relief, including termination of the agreements, damages remedy and so on.

Read more Medical News

› Verified 7 days ago

Entity NameAspire Indiana Health Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1780068288
PECOS PAC ID: 8921314196
Enrollment ID: O20150902001749

News Archive

Use of Prostate Health Index cuts down need for uncomfortable biopsies

The Prostate Health Index is a cost-effective tool used by urologists to detect prostate cancer. It reduces the risk of over diagnosis, and cuts down on the need to send men for unnecessary and often uncomfortable biopsies.

Researchers reveal how antipsychotics affect metabolism by SMAD3 activation

In a paper published January 31 in the journal Molecular Psychiatry, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) reveal how antipsychotic drugs interfere with normal metabolism by activating a protein called SMAD3, an important part of the transforming growth factor beta (TGFbeta) pathway.

WWHI participates in joint meeting to explore barriers to wireless communications, health care solutions

The West Wireless Health Institute today announced its participation in the first joint meeting hosted by the Federal Communications Commission and Food & Drug Administration to explore the potential barriers that may slow the convergence of wireless communications and health care solutions.

Novabay commences NVC-422 catheter Phase 2 trial to treat UCBE

NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing its first-in-class, anti-infective Aganocide compounds for the local non-systemic treatment and prevention of antibiotic-resistant infections, today provided an update on its Phase 2 clinical trial for the use of its lead compound, NVC-422, to prevent urinary catheter blockage and encrustation which is often a contributing factor to urinary tract infections in chronically catheterized patients.

R-Tech Ueno, Sucampo Pharmaceuticals request arbitration against Takeda Pharmaceutical

R-Tech Ueno supplies Amitiza (TM) Capsules to Takeda pursuant to agreements with Takeda and Sucampo. On March 12, 2010, Sucampo submitted for filing with the International Court of Arbitration, International Chamber of Commerce, a Request for Arbitration against Takeda. In that Request, Sucampo claimed that Takeda has violated the provisions of the October 29, 2004, Collaboration and License Agreement between Sucampo and Takeda and other applicable duties, and that Takeda's violations have injured Sucampo. Sucampo requested all appropriate relief, including termination of the agreements, damages remedy and so on.

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Amanda L Votaw is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Amanda L Votaw, LMFT
9615 E 148th St Ste 1,
Noblesville, IN 46060-4371

Ph: (317) 574-1254
Amanda L Votaw, LMFT
697 Pro Med Ln,
Carmel, IN 46032-5323

Ph: (317) 574-1254

News Archive

Use of Prostate Health Index cuts down need for uncomfortable biopsies

The Prostate Health Index is a cost-effective tool used by urologists to detect prostate cancer. It reduces the risk of over diagnosis, and cuts down on the need to send men for unnecessary and often uncomfortable biopsies.

Researchers reveal how antipsychotics affect metabolism by SMAD3 activation

In a paper published January 31 in the journal Molecular Psychiatry, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) reveal how antipsychotic drugs interfere with normal metabolism by activating a protein called SMAD3, an important part of the transforming growth factor beta (TGFbeta) pathway.

WWHI participates in joint meeting to explore barriers to wireless communications, health care solutions

The West Wireless Health Institute today announced its participation in the first joint meeting hosted by the Federal Communications Commission and Food & Drug Administration to explore the potential barriers that may slow the convergence of wireless communications and health care solutions.

Novabay commences NVC-422 catheter Phase 2 trial to treat UCBE

NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing its first-in-class, anti-infective Aganocide compounds for the local non-systemic treatment and prevention of antibiotic-resistant infections, today provided an update on its Phase 2 clinical trial for the use of its lead compound, NVC-422, to prevent urinary catheter blockage and encrustation which is often a contributing factor to urinary tract infections in chronically catheterized patients.

R-Tech Ueno, Sucampo Pharmaceuticals request arbitration against Takeda Pharmaceutical

R-Tech Ueno supplies Amitiza (TM) Capsules to Takeda pursuant to agreements with Takeda and Sucampo. On March 12, 2010, Sucampo submitted for filing with the International Court of Arbitration, International Chamber of Commerce, a Request for Arbitration against Takeda. In that Request, Sucampo claimed that Takeda has violated the provisions of the October 29, 2004, Collaboration and License Agreement between Sucampo and Takeda and other applicable duties, and that Takeda's violations have injured Sucampo. Sucampo requested all appropriate relief, including termination of the agreements, damages remedy and so on.

Read more News

› Verified 7 days ago


Marriage & Family Therapist in Carmel, IN

Robert Lee Caldwell, M.S., LMFT
Couples Therapy
Medicare: Not Enrolled in Medicare
Practice Location: 13295 Illinois St, Suite 311, Carmel, IN 46032
Phone: 317-440-4176    Fax: 775-288-3479
Jason Mcdaniel, LMFT
Couples Therapy
Medicare: Not Enrolled in Medicare
Practice Location: 697 Pro-med Ln, Carmel, IN 46032
Phone: 317-574-0055    Fax: 317-574-1230
Mrs. Laura Kusisto Snyder, MS, LMFT
Couples Therapy
Medicare: Not Enrolled in Medicare
Practice Location: 615 W Carmel Dr Ste 120, Carmel, IN 46032
Phone: 317-569-5433    Fax: 317-569-1767
Mrs. Abby Breece, MA
Couples Therapy
Medicare: Not Enrolled in Medicare
Practice Location: 1980 E 116th St, 315, Carmel, IN 46032
Phone: 317-730-5155    
Tony Langstaff,
Couples Therapy
Medicare: Not Enrolled in Medicare
Practice Location: 722 High Dr, Carmel, IN 46033
Phone: 229-630-5056    
Sara Elaine Bucksten, LMFT
Couples Therapy
Medicare: Not Enrolled in Medicare
Practice Location: 615 W Carmel Dr Ste 120, Carmel, IN 46032
Phone: 317-569-5433    Fax: 317-569-1767
Dr. Joseph Kowalow, PHD, MA, LMFTA
Couples Therapy
Medicare: Not Enrolled in Medicare
Practice Location: 2215 E 151st St Apt 4, Carmel, IN 46033
Phone: 858-213-3935    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.